PharmaBlock Sciences (Nanjing), Inc. (SZSE: 300725)
Health Care · Pharmaceuticals · CN
CN¥51.01
-7.84% today · +26.8% 1Y
PharmaBlock Sciences (Nanjing), Inc. (SZSE: 300725) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.77B and employs 2,593 people.
Over the last twelve months the share price has gained 26.8%, trading between 30.90 and 57.55.
Tweenvest scores PharmaBlock Sciences (Nanjing), Inc. across four factors: quality 68/100, value 25/100, growth 51/100, dividend 48/100. Its strongest factor is quality.
300725 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.77B
- Revenue (TTM)
- $311.24M
- P/E
- 54.17
- EPS
- 0.94
- Dividend yield
- 0.39%
- Beta (5Y)
- 0.61
- 52-week high
- CN¥57.55
- 52-week low
- CN¥30.90
- Avg volume (3M)
- —
- Shares outstanding
- 232.97M
- Employees
- 2,593
- Next earnings
- —
About PharmaBlock Sciences (Nanjing), Inc.
PharmaBlock Sciences (Nanjing), Inc. delivers a comprehensive suite of chemical products and specialized services, supporting the pharmaceutical industry across the full spectrum of its operations – from initial research and development phases to large-scale commercial production. The company's primary offerings encompass: A vast inventory of chemical building blocks, available for supply at every stage of drug creation, from early discovery through to advanced development and commercial manufacturing. The creation of diverse chemical libraries, derived from their building blocks, specifically designed to accelerate drug discovery processes. Contract development and manufacturing (CDMO) services for essential pharmaceutical components, including raw starting materials (RSMs), chemical intermediates, active pharmaceutical ingredients (APIs), and finished drug products, catering to both clinical development programs and market demands. Established in 2006, PharmaBlock Sciences maintains its corporate headquarters in Nanjing, People's Republic of China.
- ISIN
- CNE1000035K5
- Founded
- 2006
- Listed since
- Nov 10, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Septerna, Inc.NasdaqGM: SEPN | $1.79B | $38.37 | +1.75% |
| Neuren Pharmaceuticals LimitedASX: NEU | $1.79B | AU$20.20 | -0.39% |
| Zhejiang Medicine Co., Ltd.SHSE: 600216 | $1.78B | CN¥12.59 | +1.29% |
| Tsumura & Co.TSE: 4540 | $1.78B | ¥3,772.00 | +1.86% |
| Nuvation Bio Inc.NYSE: NUVB | $1.76B | $5.00 | -2.72% |
| Cohance Lifesciences LimitedNSEI: COHANCE | $1.74B | Rs441.00 | -2.28% |
| Shanghai Shyndec Pharmaceutical Co., Ltd.SHSE: 600420 | $1.70B | CN¥8.51 | +1.43% |
| Faes Farma, S.A.BME: FAE | $1.69B | €4.87 | +0.41% |
Figures last refreshed Oct 11, 2026.